U.S. Anticoagulant Rodenticides Market Size & Outlook
U.S. anticoagulant rodenticides market, 2018-2030 (US$M)
Related Markets
U.S. anticoagulant rodenticides market highlights
- The U.S. anticoagulant rodenticides market generated a revenue of USD 180.3 million in 2021 and is expected to reach USD 227.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 2.6% from 2022 to 2030.
- In terms of segment, 2nd gen was the largest revenue generating product in 2021.
- 1st Gen is the most lucrative product segment registering the fastest growth during the forecast period.
Anticoagulant rodenticides market data book summary
| Market revenue in 2021 | USD 180.3 million |
| Market revenue in 2030 | USD 227.6 million |
| Growth rate | 2.6% (CAGR from 2021 to 2030) |
| Largest segment | 2nd gen |
| Fastest growing segment | 1st Gen |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | 1st Gen, 2nd Gen |
| Key market players worldwide | Neogen Corp, Basf SE, Rentokil Initial PLC, Bayer AG, Syngenta, PelGar International, Liphatech |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.5% of the global anticoagulant rodenticides market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. anticoagulant rodenticides market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 14.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anticoagulant Rodenticides Market Scope
Anticoagulant Rodenticides Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. anticoagulant rodenticides market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulant rodenticides market will help companies and investors design strategic landscapes.
2nd gen was the largest segment with a revenue share of 58.85% in 2021. Horizon Databook has segmented the U.S. anticoagulant rodenticides market based on 1st gen, 2nd gen covering the revenue growth of each sub-segment from 2018 to 2030.
Anticoagulant rodenticides used in the U.S. are categorized as acute rodenticides, first-generation anticoagulants, and second-generation anticoagulants based on the toxicity level and mode of action.
An increase in the number of rodents across various cities including Chicago, New York City, San Francisco, Los Angeles, and Washington D.C. coupled with growing awareness regarding the diseases spread by rodents is anticipated to drive the demand for anticoagulant rodenticides over the forecast period.
Several active ingredients are registered as anticoagulant rodenticides in the U.S. including chlorophacinone, bromadiolone, difethialone, warfarin, and brodifacoum.
Reasons to subscribe to U.S. anticoagulant rodenticides market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. anticoagulant rodenticides market databook
-
Our clientele includes a mix of anticoagulant rodenticides market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. anticoagulant rodenticides market , including forecasts for subscribers. This country databook contains high-level insights into U.S. anticoagulant rodenticides market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. anticoagulant rodenticides market size, by product, 2018-2030 (US$M)
U.S. Anticoagulant Rodenticides Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
